We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Antibody Test for Anthrax

By HospiMedica staff writers
Posted on 06 Jan 2004
A lateral flow immunoassay contains a monoclonal antibody that is specific for the presence of a cell surface protein found in Bacillus anthracis vegetative cells. More...
The test has been cleared by the U.S. Food and Drug Administration (FDA).

Called RedLine Alert, the test can be used on colonies as early as 12 hours old. Attended time takes as little as 10 minutes and the test can be fully completed within 20 minutes. In the data submitted to the FDA on 145 Bacillus anthracis isolates from 28 countries around the world, the RedLine Alert was 98.6% correct. This compares favorably to the gamma phage lysis, which can require an additional day of culture and is 97.2% correct. In addition, the RedLine Alert had an accuracy of 100% in correctly differentiating B anthracis from 49 other nonhemolytic Bacilli.

The test was developed by Tetracore, Inc. (Gaithersburg, MD, USA). "We are excited to be able to provide a significant new clinical and public health tool to aid in protecting against bio-terrorism threats,” said Dr. Beverly L. Mangold, of Tetracore.





Related Links:
Tetracore

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.